Are Nufarm shares a buy, hold or sell after jumping 13% on half-year results?

This agriculture company is set to keep rising.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nufarm Ltd (ASX: NUF) shares were making headlines yesterday after the ASX materials stock soared 13% in a single session. 

Investors were gobbling up Nufarm shares after releasing its FY 2026 half-year results.

Happy female farmer holding fresh produce.

Image source: Getty Images

What did Nufarm report?

For the half year ended 31 March 2026, it reported: 

  • Statutory Net Profit After Tax $38 million, up 28% on the prior corresponding period (pcp)
  • Underlying NPAT (uNPAT) $52 million, up 35% on pcp
  • Underlying EBITDA (uEBITDA) $243 million, up 18% on pcp
  • $193 million improvement on pcp in free cash flow
  • Net debt $1.23 billion, a reduction of $135 million on pcp
  • Net debt to uEBITDA for twelve months to 31 March 2026 of 3.6x, a 20% reduction on pcp
  • FY26 Outlook for uEBITDA and Leverage reaffirmed.

Commenting on the announcement, Nufarm CEO Rico Christensen said 

We are pleased with first half performance and are well placed to deliver strong growth in underlying earnings and a significant reduction in leverage for the full year, consistent with previous guidance. 

We have made clear progress on the priorities we set in November last year, delivering earnings growth, improved cash flow and a reduction in leverage. The benefit of our increased strategic focus is visible in the margin improvement in Crop Protection and significant uplift in earnings from our Seed Technologies business.

Bell Potter weighs in 

Following this result, the team at Bell Potter issued updated guidance on Nufarm shares. 

Nufarm is one of the world's leading developers and manufacturers of seeds and crop protection solutions.

The broker noted that the company's Seeds business was a standout performer during the half. 

EBITDA more than doubled to $58 million, helped by significantly smaller losses in the omega-3 platform business.

Cash flow also improved compared with the prior year, and net debt declined to around $1.09 billion excluding leases. Debt levels finished the period in line with management guidance.

Looking ahead, management remains confident about FY26. 

The company expects strong earnings growth, supported by continued improvement in crop protection and further growth in the Seeds business. 

Nufarm is also progressing with its cost-saving program, targeting $50 million in annual savings by the end of FY26, with an additional $50 million reduction plan for FY27–28.

Upside in tact 

Based on this guidance, the team at Bell Potter retained their buy recommendation and $3.60 price target on Nufarm shares. 

From yesterday's closing price of $2.91, this indicates an upside potential of almost 24%. 

NUF is executing on its cost out initiatives ($32m of the $50m FY26e target achieved and a $50m target in FY27-28e) with a more favourable backdrop in crop protection markets and omega-3 (a doubling in fishoil pricing). Despite this NUF trades at a ~25% discount to global crop protection and seed peers.

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A group of three men in hard hats and high visibility vests stand together at a mine site while one points and the others look on with piles of dirt and mining equipment in the background.
Broker Notes

How high does Macquarie think Fortescue shares will go?

The broker is positive on the company's outlook.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Broker Notes

Experts name 3 big-name ASX 200 shares to sell

These shares are in the bad books, but for what reason?

Read more »

Two smiling work colleagues discuss an investment at their office.
Broker Notes

Why Mesoblast shares could double in value

This biotechnology company just became less risky according to Bell Potter.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: TechnologyOne, Pro Medicus, PLS Group shares

Here's what John Athanasiou from Red Leaf Securities thinks of these three ASX 200 shares.

Read more »

Miner looking at a tablet.
Broker Notes

Should you buy BHP shares FY27? Here's what experts are saying

Is another powerful rally on the cards for the mining giant?

Read more »

A trio of ASX shares analysts huddle together in an office with computer screens all around them showing share price movements
Broker Notes

Buy, hold, sell: James Hardie, Adairs, Minerals 260 shares

Morgans has updated its ratings on these three ASX shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man with rocket wings which have flames coming out of them.
Resources Shares

2 ASX mining shares that could more than double in value in FY27: experts

Bell Potter thinks these stocks have more than 100% upside potential in the new financial year.

Read more »